Intel (NSDQ:INTC) and Royal Philips (NYSE:PHG) said last week they are partnering to test Intel hardware’s ability to run deep learning artificial intelligence programs intended to improve the capabilities of Philips tech.
The two companies joined to test the abilities of hardware using Intel Xeon processors and the OpenVINO toolkit for two AI-powered programs: one for bone-age-prediction modeling based on X-rays and one examining computed tomography scans of lungs for segmentation.
